Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings Inc    ZBH

Delayed Quote. Delayed  - 09/23 10:02:01 pm
128.33 USD   -0.42%
09/22 ZIMMER BIOMET : Sep 22, 2016 Zimmer Biomet Contributes Additional $1..
09/21 ZIMMER BIOMET H : ex-dividend day
09/20 ZIMMER BIOMET : Sep 20, 2016 Zimmer Biomet Launches VANGUARD® Indivi..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Zimmer Holdings, Inc. : Morning Research on Boston Scientific, Abbott Laboratories, Medtronic, Zimmer, and EnteroMedics

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/02/2013 | 02:05pm CEST

LONDON, April 2, 2013 /PRNewswire/ --

Medical appliances & equipment makers have been critical of President Obama's Affordable Care Act (ACA). Under the healthcare reform, medical appliances & equipment makers such as Boston Scientific Corporation (NYSE: BSX), Abbott Laboratories (NYSE: ABT), Medtronic Inc. (NYSE: MDT), Zimmer Holdings Inc. (NYSE: ZMH), and EnteroMedics Inc. (NASDAQ: ETRM) are required to pay a 2.3% excise tax on U.S. sales. The industry has been lobbying to repeal the 2.3% tax on U.S. sales, saying that it would lead to higher costs and hamper research and development activities. Medical appliances & equipment makers ended mostly lower on Monday, tracking losses in the broad market. StockCall has posted free technical research reports on BSX, ABT, MDT, ZMH, and ETRM and these can be accessed by signing up at

http://www.stockcall.com/analysis

Shares of Boston Scientific Corporation touched a 52-week high of $7.86 yesterday, however, the stock failed to hold on to its gains. It closed 0.13% lower at $7.80 on above average volume of 29.66 million. Boston Scientific shares have gained more than 4.80% in the last three trading sessions. The stock has outperformed the broad market so far in 2013, gaining more than 36%. Its MACD has just crossed above the signal line, which is a strong bullish signal. Download the free report on BSX upon registration at

http://www.StockCall.com/BSX040213.pdf

Abbott Laboratories shares ended nearly flat in Monday's trading session. The stock fell to an intra-day low of $34.95 before paring most of its losses to finish the day 0.03% lower at $35.31 on volume of 6.03 million. The stock has gained nearly 2.80% in the last three sessions. Abbott's shares recently broke through $35 resistance level, which is a strong bullish signal. The positive trend is further confirmed by the stock's MACD chart. The company's shares are also trading above their 50-day and 200-day moving averages. ABT technical report can be accessed for free by signing up at

http://www.StockCall.com/ABT040213.pdf

Medtronic Inc.'s shares edged lower on Monday; however, the losses were limited. The stock closed 0.34% lower at $46.80 on volume of 2.81 million. The company's shares are currently trading close to their 52-week high of $47.40. The stock has outperformed the broad market in 2013, gaining more than 14%. Its shares are currently facing resistance at around $47. The stock's MACD is currently trading above the signal line and the zero-line, which is a bullish signal. The free report on MDT can be downloaded by signing up now at

http://www.StockCall.com/MDT040213.pdf

Zimmer Holdings Inc.'s shares ended marginally lower yesterday. The stock ended the day 0.12% lower at $75.13 on volume of 693,613. Its shares are currently hovering around their 52-week high of $76.75. The stock saw a series of highs last week, which is a bullish signal. The upbeat trend is further confirmed by recent volume activity and the stock's MACD chart. Free report on ZMH can be accessed by registering at

http://www.StockCall.com/ZMH040213.pdf

EnteroMedics Inc.'s shares rose sharply on Monday even as the broad market struggled. The stock closed 1% higher at $1.01 on volume of 776,418. EnteroMedics' shares touched an intra-day high of $1.04 yesterday. Despite the gains, the stock is down nearly 1% in the last three trading sessions. Shares of ETRM are currently trading well below their 50-day and 200-day moving averages. Register with StockCall and download the research on ETRM for free at

http://www.StockCall.com/ETRM040213.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com

SOURCE StockCall.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ZIMMER BIOMET HOLDINGS INC
09/22 ZIMMER BIOMET : Sep 22, 2016 Zimmer Biomet Contributes Additional $100,000 in Fu..
09/21 ZIMMER BIOMET HOLDINGS INC : ex-dividend day
09/20 ZIMMER BIOMET : Sep 20, 2016 Zimmer Biomet Launches VANGUARD® Individualized Des..
09/15 ZIMMER BIOMET : Earns EPA Recognition for Converting Warsaw-Indiana Headquarters..
09/15 ZIMMER BIOMET : Sep 15, 2016 Zimmer Biomet Adds 3D Range-of-Motion Simulation Ca..
09/09 ZIMMER BIOMET : Investing in India
09/08 ZIMMER BIOMET : First Minister announces key investment for Wales during visit t..
08/25 ZIMMER BIOMET : Virtual Reality, BattleBots® and Much More Take over Minneapolis..
08/25 ZIMMER BIOMET : Strengthens Musculoskeletal Diagnostic Offering with Acquisition..
08/23 ZIMMER BIOMET : Aug 23, 2016 Zimmer Biomet Announces Quarterly Dividend for Thir..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
09/17DJJ&J to Buy Abbott Eye Business -- WSJ
09/16DJJ&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- 2nd Update
09/16DJJ&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- 3rd Update
09/16DJJ&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- Update
09/16DJJ&J Nears Deal to buy Abbott's Eye-Surgery Equipment Unit
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
09/20 Zimmer Biomet launches VANGUARD Individualized Design Knee Replacement
09/15 Zimmer Biomet acquires Dutch firm Clinical Graphics
08/23 Zimmer Biomet declares $0.24 dividend
08/15 Zimmer Biomet buys musculoskeletal diagnostics testing firm
08/10 Zimmer Biomet prices equity offering; shares off 3% premarket